NCT03095612 2024-06-13Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)University of Texas Southwestern Medical CenterPhase 1/2 Terminated41 enrolled 11 charts